The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
A Prospective, Randomized, Open-Label, Multicenter Clinical Trial study to compare the efficacy and safety of ATRA plus eltrombopag compared to eltrombopag monotherapy in the treatment of steroid-resistant/relapsed immune thrombocytopenia (ITP).
Epistemonikos ID: 7368eee9c75a1708d446f727dc867d883a6da5de
First added on: May 13, 2024